• MHRA approves Venclyxto for newly diagnosed AML pharmatimes
    June 16, 2021
    The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved AbbVie and Roche’s Venclyxto for the treatment of newly diagnosed acute myeloid leukaemia (AML).
PharmaSources Customer Service